الفهرس 
IntroductionOnly 14 pages are availabe for public view
 |  | from | 64 |  |  |
| | | from | 64 | | |
Abstract
This is a retrospective study that studied the types of neurological tumors and its management. All the medical records of patients with neurological tumors were collected from the archives in the unit to provide the demographic and clinical data of the patients, their management and outcome of treatment. In this study, results showed that neurological tumors constituted 67 patients from the total number of patients ( 7465 ) attending the Suez Canal University Center of Oncology and Nuclear Medicine in a period from Jan 1995 to Dec 2011 with a relative frequency incidence of 0.9%. The total number of patients was 67, males were 35 patients (52.2%) and female patients were 32 (47.8%). The pathological distribution of the patients in this sample was as follows, with glioblastoma multiform as the most commonly occurring primary tumor and about(16.4%) of the cases had no pathological examination ;
glioblastoma multiform (25.4%), astrocytoma G1 (9%), astrocytoma G2 (9%), astrocytoma G3 (7.5%), meningioma (6%), ganglioblastoma (4%), ependymoma (4%), others(1.5%).
Headache represented (31.3%), parasthesia and drowsiness represented(4.5%) and quadrimyelopathy and urinary and/or defecation incontinences accounted for(3%) of cases.
The least common presenting symptoms were the following and each represented (1.5%) of the cases; abdominal pain, abdominal swelling, amenorrhea, infertility, acromegally, galactorrhea, otalgia, neck pain and accidental presentation. The distribution of patients according to post treatment imaging (Table 10) showed that:
• The distribution of patients according to post treatment imaging showed that the majority of the sample; 54 patients (80.6%) had free images with no residual, while those who had residual disease were 7 patients (10.4%). Other findings in post operative imaging included; Decrease size of hydrocephalus and frontal osteomalacia each represented 2 patients (3%) of the sample. Recurrence occurred only in 10 patients (14.9%), while the remaining experienced no recurrent disease (57 patients representing 85.1%). The distribution of patients according to lines of treatment given was as follows: Radiotherapy only: 21 patients (31.3%).
• Total excision and Radiotherapy: 20 patients (29.9%)
• Partial Excision and Radiotherapy: 14 patients (20.9%)
• Total excision: 4 patients (6%)
• Total excision and Chemotherapy: 2 patients (3%)
• Shunt and Radiotherapy: 2 patients (3%)
• Radiotherapy and Chemotherapy: 2 patients (3%)
• Total excision, Chemotherapy and Radiotherapy: 1 patient (1.5%)
• Cabergoline (Dostinex): 1 patient (1.5%).